https://orcid.org/0000-0002-0164-0814
References
- Lu Y , ChenY , GemeinhartRA , WuW , LiT. Developing nanocrystals for cancer treatment. Nanomedicine10(16), 2537–2552 (2015).
- Lu Y , WuW . LiT Crystalline nanoparticles. In: Pharmaceutical Crystals: Science And Engineering.LiT, MatteiA ( Eds). John Wiley & Sons, Inc, NJ, USA, 463–502 (2018).
- Muller RH , GohlaS , KeckCM. State of the art of nanocrystals – special features, production, nanotoxicology aspects and intracellular delivery. Eur. J. Pharm. Biopharm.78(1), 1–9 (2011).
- Wong J , BruggerA , KhareAet al. Suspensions for intravenous (IV) injection: a review of development, preclinical and clinical aspects. Adv. Drug Deliv. Rev.60(8), 939–954 (2008).
- Wilhelm S , TavaresAJ , DaiQet al. Analysis of nanoparticle delivery to tumours. Nat. Rev. Mater.1, 16014 (2016).
- Dai Q , WilhelmS , DingDet al. Quantifying the ligand-coated nanoparticle delivery to cancer cells in solid tumors. ACS Nano.12(8), 8423–8435 (2018).
- He H , JiangS , XieYet al. Reassessment of long circulation via monitoring of integral polymeric nanoparticles justifies a more accurate understanding. Nanoscale Horiz.3(4), 397–407 (2018).
- Lu Y , QiJ , DongX , ZhaoW , WuW. The in vivo fate of nanocrystals. Drug Discov. Today22(4), 744–750 (2017).
- Lu Y , LiY , WuW. Injected nanocrystals for targeted drug delivery. Acta Pharm. Sin. B6(2), 106–113 (2016).
- Choi J-Y , YooJY , KwakH-S , UkNam B , LeeJ. Role of polymeric stabilizers for drug nanocrystal dispersions. Curr. Appl. Phys.5(5), 472–474 (2005).
- Hollis CP , LiT. Nanocrystals production, characterization, and application for cancer therapy. In: Nanoparticulate Drug Delivery Systems: Strategies, Technologies, And Applications.YeoY ( Ed.). John Wiley & Sons, Inc, NY, USA, 181–206 (2013).
- Ren XT , QiJP , WuWet al. Development of carrier-free nanocrystals of poorly water-soluble drugs by exploring metastable zone of nucleation. Acta Pharm. Sin. B9(1), 118–127 (2019).
- Lu Y , LvY , LiT. Hybrid drug nanocrystals. Adv. Drug Deliv. Rev.143(15), 115–133 (2019).
- Wu W , LiT. Unraveling the in vivo fate and cellular pharmacokinetics of drug nanocarriers. Adv. Drug Deliv. Rev.143, 1–2 (2019).
- Qi J , HuX , DongXet al. Towards more accurate bioimaging of drug nanocarriers: turning aggregation-caused quenching into a useful tool. Adv. Drug Deliv. Rev.143, 206–225 (2019).
- Park K . Absorption of orally administered ultrafine drug particles. J. Control. Rel.270, 304 (2018).
- Xie Y , ShiB , XiaFet al. Epithelia transmembrane transport of orally administered ultrafine drug particles evidenced by environment sensitive fluorophores in cellular and animal studies. J. Control. Rel.270, 65–75 (2018).
- Shen C , YangY , ShenBet al. Self-discriminating fluorescent hybrid nanocrystals: efficient and accurate tracking of translocation via oral delivery. Nanoscale10(1), 436–450 (2018).
- Liu D , WanB , QiJet al. Permeation into but not across the cornea: bioimaging of intact nanoemulsions and nanosuspensions using aggregation-caused quenching probes. Chin. Chem. Lett.29(12), 1834–1838 (2018).